Current advance in treatment of infective keratitis by UVA-Riboflavin cross-linking

Abstract:

Corneal collagen cross-linking(CXL)is the latest corneal shape technology applied in clinic. CXL can increase corneal rigidity after collagen cross-linking used ultraviolet A. CXL also can increase the mechanical and biochemical stability of the stroma tissue and prevent the progression of corneal expansion and the refractory corneal ulcer.